A Mission of the Heart
PharmExec
NOVEMBER 8, 2022
Christi Shaw, CEO of Kite, is working hard to bring cell therapy to the masses, fueled by her family’s personal experiences with cancer.
a-mission-of-the-heart 
STAT+: A digital pill shows early promise in detecting opioid overdose, sleep apnea
STAT
NOVEMBER 17, 2023
A team of researchers has tested Celero’s device in humans for the first time, successfully capturing heart and respiratory data in 10 patients with sleep apnea. A team of researchers has tested Celero’s device in humans for the first time, successfully capturing heart and respiratory data in 10 patients with sleep apnea.
122 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Lexicon gets FDA approval for Inpefa to treat heart failure
Pharmaceutical Technology
MAY 29, 2023
Lexicon Pharmaceuticals (Lexicon) has received approval from the US Food and Drug Administration (FDA) for its Inpefa drug to treat heart failure. It is intended to lower the risk of cardiovascular death, urgent heart failure visit, and hospitalisation for heart failure.
FDA 98
98 
Essential SEO Strategies for Nonprofits
Mission-Driven Marketing Blog
NOVEMBER 14, 2023
SEO is your ally in this mission, helping to ensure your organization stands out and reaches the hearts and minds of potential supporters. SEO is your ally in this mission, helping to ensure your organization stands out and reaches the hearts and minds of potential supporters.
52 
STAT+: Invitae’s new CEO on why the genetic testing firm stopped chasing ‘volume at all costs’
STAT
JANUARY 16, 2023
SAN FRANCISCO — Invitae, a Bay Area genetic testing company with a mission to use genomic information to improve health care, has struggled to turn that mantra into a solid business model. It’s now trying to turn things around. Invitae also announced that its Chief Operating Officer, Ken Knight, would take over as CEO.
92 
PODCAST: Understanding NF2 with Grace Gregory and Gareth Evans
NF2 BioSolutions
MARCH 25, 2024
Our mission is to foster a better understanding of NF2 and create a supportive community for those affected. Our mission is to foster a better understanding of NF2 and create a supportive community for those affected. Despite its profound impact on people with NF2 and their families, NF2 remains largely unknown to the general public.
69 
WHO adds cardiovascular polypill to List of Essential Medicines
Hospital Pharmacy Europe
AUGUST 7, 2023
Developed by the Spanish National Centre for Cardiovascular Research (CNIC ) in conjunction with the Ferrer Foundation , the cardiovascular polypill has been proven to be effective in preventing cardiovascular events after a heart attack. The results showed that the primary outcome occurred in 9.5% for superiority).
Dosage 96
96 
Clinical Excellence in Cardiovascular Care: a new event
Hospital Pharmacy Europe
APRIL 12, 2023
Hear the latest developments and innovations in cardiovascular care at a new free event being held in May 2023 In support of our mission to provide high-quality clinical education, Hospital Healthcare Europe , together with Hospital Pharmacy Europe, is proud to announce a new series of events in 2023: the HHE Clinical Excellence programme.
Hospitals 95
95 Hospitals 95
95 
What Are Pharmacy Students Up To These Days Anyways? – A Look At The ChatRx Podcast
IDStewardship
OCTOBER 18, 2023
As many of us know, pharmacy school, and the profession as a whole, is not for the faint of heart; it often comes with challenges and learning curves we are not fully prepared for. In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor.
182 
Rocket agrees to acquire biotech firm Renovacor
Pharmaceutical Technology
SEPTEMBER 21, 2022
It leverages gene transfer technology to target the monogenic cause of BAG3-linked dilated cardiomyopathy (DCM), a severe kind of heart failure. . The Renovacor takeover is expected to further bolster the expertise of Rocket in AAV-based cardiac gene therapy, as well as support its near-term clinical assets to treat heart ailments. .
59 
BioCryst gains marketing authorisation for Orladeyo in Chile
Pharmaceutical Technology
MAY 23, 2023
Extra doses of ORLADEYO above 150mg once daily are not suggested as this could lead to prolongation of the QT [a measure of the heart’s electrical activity]. ORLADEYO is an oral therapy that has been primarily developed to prevent HAE attacks by inhibiting plasma kallikrein activity.
52 
Astellas Pharma signs licence deal with Kate Therapeutics for KT430
Pharmaceutical Technology
JUNE 9, 2023
Astellas Pharma chief strategy officer Adam Pearson stated: “This agreement brings together Astellas and KateTx’s collective patient-focused missions, allowing us to evaluate how to advance this new potential therapy for people diagnosed with XLMTM. It delivers a functional copy of the MTM1 gene through a new MyoAAV capsid to treat XLMTM.
59 
A Relaxing Oasis in The Medical District
Dr. Jamie Hardy: The Lifestyle Pharmacist
DECEMBER 5, 2022
The atmosphere was so warm and comfy that I forgot that it was nestled in the heart of the Medical District. I was a woman on a mission. Cozy, comfortable, and carefree are the feelings that come to mind when I think about my recent self-care hiatus. The best part is that I didn’t have to travel far. It’s yoga time.
98 
Elevating Clinical Quality Assurance: The AI Advancement at MedWatchers
PQA
DECEMBER 20, 2023
In the heart of communities, pharmacists stand as the lifelines of accessible healthcare education. This guest blog is one in a series by sponsors of the 2023 PQA Leadership Summit on elevating clinical quality assurance. The views shared in this series are those of the author and do not reflect any PQA positions.
Patient Care 81
81 Patient Care 81
81 
Itamar Kandel, CEO of Vista.ai Shares his Views on its Commercial Agreement with Siemens Healthineers for AI-Driven MRI Scanners
PharmaShots
APRIL 4, 2023
The company initially targeted cardiac MRI (CMR) as it is increasingly considered the gold-standard cardiac diagnostic, yet the heart is a notoriously difficult and time-consuming anatomy to scan. Shots: Itamar gave a brief overview of Vista.ai’s and Siemens Healthineers. Shots: Itamar gave a brief overview of Vista.ai’s
Hospitals 40
40 
NICE unlocks use of Amarin’s Vazkepa in 425k NHS patients
pharmaphorum
JULY 15, 2022
That includes people who have suffered a prior stroke or heart attack, or who have other conditions like unstable angina or peripheral artery disease. mmol/litre or above) in their blood who are already taking statins. mmol/litre or above) in their blood who are already taking statins. mmol/litre and below or equal to 2.60 mmol/litre.
The Hard Part of Focus
The Honest Apothecary
APRIL 29, 2022
Focus requires that we define our goals, our vision, our mission with language that gets to the very heart of our deepest desire and passion. Much time and energy is expended to create this narrow list of items that align with their mission and will be executed in the coming months. What you focus on, you will get better at.
52 
Metformin interactions to avoid
The Checkup by Singlecare
NOVEMBER 30, 2023
The most concerning reaction resulting from metformin drug interactions is lactic acidosis , a life-threatening change in our body’s chemical balance that can be heightened by kidney, liver, or heart disease. Metformin is the first-line drug of choice prescribed by medical professionals for Type 2 diabetes treatment.
Labelling 52
52 
Helina Blogs: Living in Duality
Colors Make me Happy
MARCH 2, 2023
A person cannot physically be in two places at once, but their mind and soul certainly can be. When I landed in America as a teenager, I had no doubt that I was a Kurdish refugee from Iraqi Kurdistan. Being young, America quickly made its way into my mind, body, and soul—and I’m glad that it did. But after that, the duality set in.
98 
GSK’s Neale Belson on building trust with employees and society
pharmaphorum
JANUARY 15, 2021
When I was young, I had a strong desire to make a difference, and making a difference is right at the heart of GSK’s mission.”. Our employees’ friends and colleagues understand the great work we’re doing, which has changed how they feel about working for GSK and how they are engaged in our mission”. “To
Vaccines 105
105 Vaccines 105
105 
Healx deploys its AI in hunt for Friedreich’s ataxia therapies
pharmaphorum
APRIL 9, 2021
FA is caused by a mutation in a gene that encodes a protein called frataxin and typically symptoms start to develop sometime before the age of 18, including clumsiness and frequent falls, difficulties with speech and swallowing, abnormal curvature of the spine and heart problems.
80 
Withings adds content to wearables range with 8fit acquisition
pharmaphorum
FEBRUARY 2, 2022
“We now feel it’s key to enter the era of the ‘product-service-data,’ combining personal health data with personalised wellness plans, and further deliver on our mission to empower anyone to be healthier in the long-run,” said Withings chief executive Mathieu Letombe.
Chemotherapy 63
63 Chemotherapy 63
63 
Life sciences faces a battle with sustainability, but let’s not forget its successes
pharmaphorum
DECEMBER 21, 2022
We know that the global healthcare sector is a contributor to the warming of our planet. It is responsible for 4.4% of annual carbon emissions; if the sector were a country, it would be the world’s fifth biggest global carbon emitter. Two-thirds – 67% – of life sciences companies surveyed had not set a Net Zero target in 2022. Challenges.
98 
Leo puts target on Dupixent in US as FDA clears tralokinumab
pharmaphorum
DECEMBER 29, 2021
Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma’s rival antibody tralokinumab. Leo now says it will start rolling the new product out in February. It continues to grow strongly with Sanofi reporting a 53% rise in sales to more than $4.1
FDA 110
110 
Navigating Regulatory Challenges in Pharma Marketing: Best Practices
Pharma Marketing Network
AUGUST 9, 2023
Develop Clear and Balanced Messaging Effective communication is at the heart of pharmaceutical marketing. The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Keep thorough records of approvals for future reference.
Packaging 52
52 
Microsoft puts AI at heart of digital health strategy with Nuance deal
pharmaphorum
APRIL 16, 2021
Aligned with a shared mission, together we will empower others with technology that helps them achieve EVEN more! Microsoft has made its aspirations in digital health clear with a whopping $19.7 Nuance CEO Mark Benjamin will retain his role, reporting to Scott Guthrie, executive vice president of Cloud & AI at Microsoft.
Leadership Series IV: Organizational Culture
Colors Make me Happy
MAY 10, 2021
Do not confuse organizational culture with a company’s strategic goals, core values, mission, or vision. An organization is only as good as its culture—and building that culture is not only a role for the human resources (HR) department, but it is also every leader’s responsibility. It is important to first define organizational culture.
Overcoming the challenges of developing vaccines in an accelerated timeframe
pharmaphorum
NOVEMBER 20, 2022
COVID-19 set new expectations for how quickly R&D can move; the Coalition for Epidemic Preparedness Innovations (CEPI) has since established a 100 Days Mission for responding to the next Disease X, but what needs to happen for this to become a reality? The COVID-19 pandemic stopped the world in its tracks.
Vaccines 98
98 
Navigating Regulatory Challenges in Pharma Marketing: Best Practices
Pharma Marketing Network
AUGUST 9, 2023
Develop Clear and Balanced Messaging Effective communication is at the heart of pharmaceutical marketing. The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Keep thorough records of approvals for future reference.
Packaging 40
40 
The mysterious UK Life Sciences Council
pharmaphorum
DECEMBER 8, 2022
Axel Heitmueller, managing director at Imperial College Health Partners, posted before the Council met on 28 November 2022, suggesting that the Council meeting should send out a strong message from the government that innovation will be at the heart of healthcare recovery. Yet, details on the LSC remain sparse, at least in the public domain.
Documentation 105
105 Documentation 105
105 
Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)
pharmaphorum
NOVEMBER 9, 2022
It goes without saying that The Economist’s 8th Annual World Cancer Series congress was well-attended in Brussels this week, the unofficial capital of the European Union. The essential aim? To reach for and enact “universally excellent cancer control and cancer outcomes across the continent.”. Seeking EU-wide excellence.
Insurance 98
98 Insurance 98
98 
What we’re expecting in 2021, and beyond…
pharmaphorum
JANUARY 26, 2021
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare.
Navigating Innovation and Insights: Unveiling the Gems of the NACDS Total Store Expo for Independent Pharmacy
DiversifyRx
AUGUST 18, 2023
Guest Blog by DiversifyRx CRO, Heather Haro In a constantly evolving independent pharmacy landscape, staying up-to-date with the latest products, services, and strategies is vital for pharmacy owners. I am a real nerd for this stuff! I am a real nerd for this stuff! Hallmark’s mailbox to send a card on them!
Digital investment promises to accelerate the use of wearable sensor data in clinical trials
pharmaphorum
APRIL 11, 2022
You need the purest waveform to measure heart rate accurately, but when you’re moving around, a wrist-worn device may integrate a lot of ‘noise’ in the data. Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments.
Why I Decided to Create the Adrenal Transformation Protocol
The Thyroid Pharmacist
APRIL 5, 2023
It’s been an honor and a gift to serve you on your healing journey. I am humbled that over the last decade as the Thyroid Pharmacist, I have had the pleasure of reaching almost one million people with thyroid conditions through my books, programs, social media channels, The Thyroid Secret series, and the very newsletter you are now reading.
Immunization 54
54 Immunization 54
54 
Whitney Stewart, Director of Clinical Project Management at Curebase Shares Insights from the Release of a Publication with Digital Therapeutics Alliance
PharmaShots
FEBRUARY 14, 2023
Firstly, I would like to start with understanding the deal details between Digital Therapeutics Alliance (DTA) and Curebase (financial and commercial details). The partnership is focused on education rather than commercial activities. In the U.S., the Code of Federal Regulations outlines the requirements for both product types.
FDA 40
40 
Whitney Stewart, Director of Clinical Project Management at Curebase Shares Insights from the Release of a Publication with Digital Therapeutics Alliance
PharmaShots
FEBRUARY 14, 2023
Firstly, I would like to start with understanding the deal details between Digital Therapeutics Alliance (DTA) and Curebase (financial and commercial details). The partnership is focused on education rather than commercial activities. In the U.S., the Code of Federal Regulations outlines the requirements for both product types.
FDA 40
40 
Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation
pharmaphorum
APRIL 15, 2021
Our mission is to turn innovative science into value for patients and we are working in a lot of different areas with high unmet need,” says Stef Schutte, Astellas’ head of regulatory affairs. “Our When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. Collaboration accelerates progress for patients.
Labelling 71
71 
3. Surviving Medical School with Dr. Tess Calcagno | The Physician Pharmacist Podcast
The Physician Pharmacist
SEPTEMBER 26, 2023
She discusses her experiences with international medical missions and how they have shaped her understanding of healthcare disparities worldwide. She discusses her experiences with international medical missions and how they have shaped her understanding of healthcare disparities worldwide. Here's a featured episode below!
14 Safety Signals for Adrenal Healing
The Thyroid Pharmacist
APRIL 23, 2023
Some signals indicate a threat. These include obvious red flags, such as an infection or toxin, as well as ones you may not have considered, such as inadequate sleep, overexercising, erratic blood sugar levels, poor nutrition, intestinal permeability, and mental and emotional stress (a.k.a. life in the modern world).
Twenty Women Leaders In Healthcare Industry
PharmaShots
MARCH 9, 2023
We are esteemed and elated to present a list of the 20 women who have excelled in reaching the summit of excellence, arranged alphabetically Total experience: 16 yrs. Present company and time period: Pfizer (2 yrs.) Award & Nominations: Aida has been bestowed with many coveted and prestigious awards.
FDA 40
40 
6. Pharmacist to Infectious Disease Physician with Dr. Brandon J. Smith
The Physician Pharmacist
OCTOBER 19, 2023
️ Join us for an inspiring and informative Episode 6 of The Physician Pharmacist Podcast, where we have the privilege of sitting down with Dr. Brandon J. Smith, a newly appointed Infectious Disease Attending Physician. Dr. Smith shares his firsthand experience and valuable advice for prospective medical students.
Harness the PharmD Power to be a Rockstar Engineer
The Nontraditional Pharmacist
AUGUST 19, 2019
Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network. Boy we have a great show today. Special guest, David Vu, is joining The Nontraditional Pharmacist show today and he’s a great TNP guest for a couple of reasons. So David welcome to TNP, thanks for joining. David [00:00:34] Hey Matt.
FDA approves bluebird bio’s Skysona to treat cerebral adrenoleukodystrophy
Pharmaceutical Technology
SEPTEMBER 19, 2022
bluebird bio CEO Andrew Obenshain said: “Children with CALD and their families have been at the heart of bluebird’s mission since the company was founded more than a decade ago. The treatment is indicated for usage in boys aged four to 17 years with CALD. 1) in Skysona-treated and untreated subjects. thalassemia.
FDA 98
98 
Let's personalize your content